医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2012年
33期
39-40
,共2页
余莲%赖勤%陈隆天%黄建清%吴维颢%吴爱瑜%罗必华%田畔%陈旭艳%李华
餘蓮%賴勤%陳隆天%黃建清%吳維顥%吳愛瑜%囉必華%田畔%陳旭豔%李華
여련%뢰근%진륭천%황건청%오유호%오애유%라필화%전반%진욱염%리화
自体外周造血干细胞%移植%血管疾病%糖尿病足
自體外週造血榦細胞%移植%血管疾病%糖尿病足
자체외주조혈간세포%이식%혈관질병%당뇨병족
autologous peripheral blood stem cels%transplantation%vascular disease%diabetes foot
目的观察自体外周造血干细胞移植治疗下肢缺血性血管病的疗效.方法2004年8月-2012年5月住院下肢缺血性血管病51例,其中下肢闭塞性动脉硬化症25例,糖尿病足23例,血栓闭塞性脉管炎3例,发生足部溃疡或坏疽22例.双下肢病变38例,单肢病变13例,共移植89条下肢.全部患者均给予rhG-CSF 600ug/d皮下注射,行BPSC动员4天,第5天用血细胞分离机采集单个核细胞(MNC)悬液总量80-120ml,MNC数量(306.3-670.6)×109/L.将MNC悬液按3cm×3cm距离行双下肢肌肉内注射,每点0.3-0.5ml.结果移植后6个月疼痛评分及肢冷感评分明显改善,间歇性跛行、经皮氧分压、皮肤温度移植后3、6个月比较差异均有显著性意义(P<0.05).移植后踝肱指数升降不一,10例足部溃疡好转,23例DSA或CTA结果显示新侧支血管形成明显增加.结论 APBSC移植可改善缺血性下肢血管病的临床症状及客观指标,是缺血性下肢血管病治疗的一种有效方法.
目的觀察自體外週造血榦細胞移植治療下肢缺血性血管病的療效.方法2004年8月-2012年5月住院下肢缺血性血管病51例,其中下肢閉塞性動脈硬化癥25例,糖尿病足23例,血栓閉塞性脈管炎3例,髮生足部潰瘍或壞疽22例.雙下肢病變38例,單肢病變13例,共移植89條下肢.全部患者均給予rhG-CSF 600ug/d皮下註射,行BPSC動員4天,第5天用血細胞分離機採集單箇覈細胞(MNC)懸液總量80-120ml,MNC數量(306.3-670.6)×109/L.將MNC懸液按3cm×3cm距離行雙下肢肌肉內註射,每點0.3-0.5ml.結果移植後6箇月疼痛評分及肢冷感評分明顯改善,間歇性跛行、經皮氧分壓、皮膚溫度移植後3、6箇月比較差異均有顯著性意義(P<0.05).移植後踝肱指數升降不一,10例足部潰瘍好轉,23例DSA或CTA結果顯示新側支血管形成明顯增加.結論 APBSC移植可改善缺血性下肢血管病的臨床癥狀及客觀指標,是缺血性下肢血管病治療的一種有效方法.
목적관찰자체외주조혈간세포이식치료하지결혈성혈관병적료효.방법2004년8월-2012년5월주원하지결혈성혈관병51례,기중하지폐새성동맥경화증25례,당뇨병족23례,혈전폐새성맥관염3례,발생족부궤양혹배저22례.쌍하지병변38례,단지병변13례,공이식89조하지.전부환자균급여rhG-CSF 600ug/d피하주사,행BPSC동원4천,제5천용혈세포분리궤채집단개핵세포(MNC)현액총량80-120ml,MNC수량(306.3-670.6)×109/L.장MNC현액안3cm×3cm거리행쌍하지기육내주사,매점0.3-0.5ml.결과이식후6개월동통평분급지랭감평분명현개선,간헐성파행、경피양분압、피부온도이식후3、6개월비교차이균유현저성의의(P<0.05).이식후과굉지수승강불일,10례족부궤양호전,23례DSA혹CTA결과현시신측지혈관형성명현증가.결론 APBSC이식가개선결혈성하지혈관병적림상증상급객관지표,시결혈성하지혈관병치료적일충유효방법.
Objective To observe the clinical efficacy of autologous peripheral blood stem cels(APBSC)transplantation with ischemic lower extremity disorder. Methods From August 2004 to May 2012, 51 patients with 28 case of various lower extremity ischemic disorder and 23case of diabetic foot received rhG-CSF 600ug/d by hypodemic injection for 4 days to molilize stem cels. On the fifth day,PBSC were colected with MCS+blood cel separator and prepared into stem cel suspension for limb transplantation by 3cm×3cm distance. The number of mononuclear cels is (306.3-670.6) ×109/L. Results After treatment for 6 months, the pain score and cold sensation of affected limbs score were improved .There were significant differences in intermitten claudication of lower limbs score, transcutaneous oxygen partial pressure and skin temperature after 3 or 6 months treatment (P<0.05). There was no significant difference in ankiel brachial index after treatment. Improvement of foot ulcer in 10 cases. DSA or CTA scores were performed in 23 patients, there was formation of new colateral vessels. Conclusion The clinical symptoms and objective indexes of lower extremity ischemic disorder were improved after APBSC transplantation. APBSC transplantation might be a safe and effective method for lower extremity ischemic disorder.